Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.94% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares Core MSCI EAFE ETF
IEFA
$196B
| $480M | 0.13% |
7,107,003
+332,314
| +5% | +$22.5M |
|
152
Deere & Co
DE
$167B
| $480M | 0.13% |
1,183,455
-366,420
| -24% | -$140M |
|
153
Intel
INTC
$509B
| $477M | 0.13% |
14,276,358
+5,000,316
| +54% | +$157M |
|
|
SCHR
154
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $477M | 0.13% |
19,358,380
+2,241,940
| +13% | +$56.2M |
|
155
Oracle
ORCL
$442B
| $472M | 0.12% |
3,962,691
-7,358
| -0.2% | -$761K |
|
|
156
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $471M | 0.12% |
1,063,300
-2,211,400
| -68% | -$928M |
|
157
Open Text
OTEX
$5.8B
| $470M | 0.12% |
11,300,039
-1,253,356
| -10% | -$50.3M |
|
158
Goldman Sachs
GS
$302B
| $467M | 0.12% |
1,448,050
+66,720
| +5% | +$21.9M |
|
159
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $456M | 0.12% |
11,198,058
+48,742
| +0.4% | +$1.97M |
|
160
Constellation Brands
STZ
$22.9B
| $453M | 0.12% |
1,839,914
+98,567
| +6% | +$23.1M |
|
161
S&P Global
SPGI
$121B
| $450M | 0.12% |
1,121,563
+96,257
| +9% | +$35.2M |
|
162
Truist Financial
TFC
$64.3B
| $445M | 0.12% |
14,652,089
+999,961
| +7% | +$31.1M |
|
163
Edwards Lifesciences
EW
$53.6B
| $443M | 0.12% |
4,695,771
+226,787
| +5% | +$19.7M |
|
164
Lowe's Companies
LOW
$121B
| $441M | 0.12% |
1,954,025
+559,408
| +40% | +$116M |
|
165
Dominion Energy
D
$59.8B
| $440M | 0.12% |
8,498,904
+635,741
| +8% | +$34.6M |
|
166
Becton Dickinson
BDX
$50B
| $440M | 0.12% |
1,665,579
+99,110
| +6% | +$25.2M |
|
167
MarketAxess Holdings
MKTX
$5.72B
| $437M | 0.11% |
1,672,670
-21,741
| -1% | -$6.49M |
|
168
Vertex Pharmaceuticals
VRTX
$133B
| $428M | 0.11% |
1,217,566
+91,890
| +8% | +$31M |
|
169
Wells Fargo
WFC
$269B
| $428M | 0.11% |
10,032,859
+1,261,934
| +14% | +$50.8M |
|
170
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $426M | 0.11% |
3,213,019
+1,181,293
| +58% | +$156M |
|
171
CALL
Microsoft
MSFT
$3.66T
| $424M | 0.11% |
1,246,000
+1,095,200
| +726% | +$343M |
|
172
iShares Russell 1000 Growth ETF
IWF
$128B
| $423M | 0.11% |
6,149,836
-168,168
| -3% | -$10.7M |
|
173
Yum China
YUMC
$16.4B
| $423M | 0.11% |
7,482,103
+99,581
| +1% | +$6.01M |
|
174
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $418M | 0.11% |
4,552,388
-272,862
| -6% | -$25M |
|
175
Automatic Data Processing
ADP
$107B
| $417M | 0.11% |
1,896,410
+450,132
| +31% | +$97.1M |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.